comparemela.com
Home
Live Updates
Healthtech Fund - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Healthtech fund - Page 1 : comparemela.com
Vessi Medical Closes $16 5M Series A Funding Round
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Ha afon
Eyal kochavi
Trendlines group
Israel healthtech fund
Vessi medical
Healthtech fund
Transurethral resection
Bladder tumor
Cryotherapy technology company Vessi Medical scores $16 5M and more digital health fundings
Merit Medicine, which offers AI technology to self-funded employers, also secured investment.
Mike marcantonio
Eyal kochavi
Israel healthtech fund
Vessi medical
Healthtech fund
Live oak ventures
Merit medicine
Bladder cancer treatment co Vessi Medical raises $16 5m
Vessi's minimally invasive solution for NMIBC provides a new therapeutic alternative to transurethral resection of bladder tumor.
United kingdom
Vincent tchenguiz
Eyal kochavi
Christopher ratcliffe
Consensus business group
Trendlines group
Israel healthtech fund
Vessi medical
Healthtech fund
Tchenguiz photo
Vessi Medical Closes $16 5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
/PRNewswire/ Vessi Medical Ltd. ("Vessi") announced today that it has closed a Series A financing round of $16.5 million for its cryotherapy technology to.
Ha afon
United kingdom
Vincent tchenguiz
Michel habib
Rafi beyar
Eyal kochavi
Israel innovation authority
Vessi medical ltd
Trendlines group
Israel healthtech fund
Consensus business group
Vessi medical
Non muscle invasive bladder cancer
Healthtech fund
Transurethral resection
Bladder tumor
Vessi Medial raises $16 5M for cryotherapy for bladder cancer
Vessi Medical announced today that it closed a Series A financing round worth $16.5 million to support its cryotherapy technology.
Ha afon
Eyal kochavi
Rafi beyar
Healthtech fund
Trendlines group
Vessi medical
Israel based vessi
Isreal healthtech fund
General partner rafi beyar
vimarsana © 2020. All Rights Reserved.